# Rajiv Agarwal

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/rajiv-agarwal/

## Facts

| Field | Value |
| --- | --- |
| Citations | 19,214 |
| Field | Blood Pressure and Hypertension Studies |
| h-index | 69 |
| i10-index | 200 |
| Last Known Institution | University of Indianapolis |
| OpenAlex ID | https://openalex.org/A5089305017 |
| ORCID iD | 0000-0002-3146-7231 |
| Works | 513 |

## Researcher papers

Showing 12 of 18.

- [Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes](https://scholariq.org/papers/effect-of-finerenone-on-chronic-kidney-disease-outcomes-in-type-2-diabetes/)
- [Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy](https://scholariq.org/papers/effect-of-finerenone-on-albuminuria-in-patients-with-diabetic-nephropathy/)
- [Molecular mechanisms and therapeutic targets for diabetic kidney disease](https://scholariq.org/papers/molecular-mechanisms-and-therapeutic-targets-for-diabetic-kidney-disease/)
- [Assessing the Accuracy and Reliability of AI-Generated Medical Responses: An Evaluation of the Chat-GPT Model](https://scholariq.org/papers/assessing-the-accuracy-and-reliability-of-ai-generated-medical-responses-an/)
- [Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy](https://scholariq.org/papers/effect-of-oral-methylprednisolone-on-clinical-outcomes-in-patients-with-iga/)
- [Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States](https://scholariq.org/papers/prevalence-treatment-and-control-of-hypertension-in-chronic-hemodialysis/)
- [Accuracy and Reliability of Chatbot Responses to Physician Questions](https://scholariq.org/papers/accuracy-and-reliability-of-chatbot-responses-to-physician-questions/)
- [Role of Home Blood Pressure Monitoring in Overcoming Therapeutic Inertia and Improving Hypertension Control](https://scholariq.org/papers/role-of-home-blood-pressure-monitoring-in-overcoming-therapeutic-inertia-and/)
- [Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial](https://scholariq.org/papers/patiromer-versus-placebo-to-enable-spironolactone-use-in-patients-with-resistant/)
- [Dry-Weight Reduction in Hypertensive Hemodialysis Patients (DRIP)](https://scholariq.org/papers/dry-weight-reduction-in-hypertensive-hemodialysis-patients-drip/)
- [Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy](https://scholariq.org/papers/effect-of-oral-methylprednisolone-on-decline-in-kidney-function-or-kidney/)
- [Cardiovascular complications in chronic kidney disease: a review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association](https://scholariq.org/papers/cardiovascular-complications-in-chronic-kidney-disease-a-review-from-the/)

## Researcher topics

- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Hormonal Regulation and Hypertension](https://scholariq.org/topics/hormonal-regulation-and-hypertension/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Researcher university

- [University of Indianapolis](https://scholariq.org/institutions/university-of-indianapolis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.